• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

First case of hemophagocytic lymphohistiocytosis secondary to cabozantinib with checkpoint inhibitors.

作者信息

Azari Arianna E, Stratton Richard, Singh Animesh

机构信息

Centre for Rheumatology, Royal Free Hospital and University College Medical School, London, UK.

出版信息

Rheumatology (Oxford). 2021 May 14;60(5):e167-e168. doi: 10.1093/rheumatology/keaa750.

DOI:10.1093/rheumatology/keaa750
PMID:33280022
Abstract
摘要

相似文献

1
First case of hemophagocytic lymphohistiocytosis secondary to cabozantinib with checkpoint inhibitors.卡博替尼联合检查点抑制剂继发噬血细胞性淋巴组织细胞增生症的首例病例。
Rheumatology (Oxford). 2021 May 14;60(5):e167-e168. doi: 10.1093/rheumatology/keaa750.
2
Secondary haemophagocytic lymphohistiocytosis due to checkpoint inhibitor therapy.检查点抑制剂治疗所致继发性噬血细胞性淋巴组织细胞增生症
Eur J Cancer. 2019 Jul;115:84-87. doi: 10.1016/j.ejca.2019.04.026. Epub 2019 May 23.
3
Severe hemophagocytic lymphohistiocytosis in a melanoma patient treated with ipilimumab + nivolumab.黑色素瘤患者接受伊匹单抗+纳武单抗治疗后发生严重噬血细胞性淋巴组织细胞增生症。
J Immunother Cancer. 2018 Jul 16;6(1):73. doi: 10.1186/s40425-018-0384-0.
4
Haemophagocytic lymphohistiocytosis associated with immune checkpoint inhibitors: a descriptive case study and literature review.免疫检查点抑制剂相关噬血细胞性淋巴组织细胞增生症：一项描述性病例研究及文献综述
Br J Haematol. 2020 Jun;189(5):985-992. doi: 10.1111/bjh.16630. Epub 2020 Apr 3.
5
Immune checkpoint inhibitors myocarditis: not all cases are clinically patent.免疫检查点抑制剂相关性心肌炎：并非所有病例在临床上都很明显。
Eur Heart J. 2018 Oct 7;39(38):3553. doi: 10.1093/eurheartj/ehy485.
6
Magnetic resonance imaging criteria of immune checkpoint inhibitor-induced hypophysitis.免疫检查点抑制剂诱导的垂体炎的磁共振成像标准。
Curr Probl Cancer. 2021 Feb;45(1):100644. doi: 10.1016/j.currproblcancer.2020.100644. Epub 2020 Aug 29.
7
Nivolumab and Ipilimumab-induced myositis and myocarditis mimicking a myasthenia gravis presentation.纳武单抗和伊匹单抗诱发的肌炎和心肌炎，表现类似重症肌无力。
Neuromuscul Disord. 2020 Jan;30(1):67-69. doi: 10.1016/j.nmd.2019.10.006. Epub 2019 Nov 4.
8
Autoimmune hypophysitis secondary to therapy with immune checkpoint inhibitors: Four cases describing the clinical heterogeneity of central endocrine dysfunction.免疫检查点抑制剂治疗继发的自身免疫性垂体炎：4例描述中枢内分泌功能障碍的临床异质性
J Oncol Pharm Pract. 2020 Oct;26(7):1774-1779. doi: 10.1177/1078155220910202. Epub 2020 Mar 12.
9
Activity of cabozantinib after immune checkpoint blockade in metastatic clear-cell renal cell carcinoma.卡博替尼在转移性透明细胞肾细胞癌免疫检查点阻断后的活性。
Eur J Cancer. 2020 Aug;135:203-210. doi: 10.1016/j.ejca.2020.05.009. Epub 2020 Jun 27.
10
Adverse events of nivolumab plus ipilimumab versus nivolumab plus cabozantinib: a real-world pharmacovigilance study.纳武利尤单抗联合伊匹单抗与纳武利尤单抗联合卡博替尼的不良反应：一项真实世界的药物警戒研究。
Int J Clin Pharm. 2024 Jun;46(3):745-750. doi: 10.1007/s11096-024-01713-1. Epub 2024 Apr 17.

引用本文的文献

1
Tislelizumab-induced hemophagocytic lymphohistiocytosis in a patient with microsatellite instability-high colon cancer and coexisting systemic lupus erythematosus: a case report and literature review.替雷利珠单抗诱导的噬血细胞性淋巴组织细胞增生症在一名微卫星高度不稳定的结肠癌合并系统性红斑狼疮患者中的病例报告及文献复习
Front Oncol. 2025 Aug 6;15:1585133. doi: 10.3389/fonc.2025.1585133. eCollection 2025.
2
Immunotherapy-related secondary hemophagocytosis in a glioblastoma patient: response to cytokine-directed therapy.胶质母细胞瘤患者中与免疫治疗相关的继发性噬血细胞增多症：对细胞因子导向治疗的反应
Immunotherapy. 2025 Jan;17(1):11-17. doi: 10.1080/1750743X.2025.2451604. Epub 2025 Jan 15.
3
Hemophagocytic lymphohistiocytosis/cytokine release syndrome secondary to neoadjuvant pembrolizumab for triple-negative breast cancer: a case study.
新辅助派姆单抗治疗三阴性乳腺癌继发噬血细胞性淋巴组织细胞增生症/细胞因子释放综合征：病例报告
Front Oncol. 2024 Jun 11;14:1394543. doi: 10.3389/fonc.2024.1394543. eCollection 2024.
4
Hemophagocytic lymphohistiocytosis following pembrolizumab and bevacizumab combination therapy for cervical cancer: a case report and systematic review.帕博利珠单抗联合贝伐珠单抗治疗宫颈癌后噬血细胞性淋巴组织细胞增生症：病例报告及系统评价。
BMC Geriatr. 2024 Jan 8;24(1):32. doi: 10.1186/s12877-023-04625-3.
5
Hemophagocytic Lymphohistiocytosis Associated with Immunological Checkpoint Inhibitors: A Pharmacovigilance Study.免疫检查点抑制剂相关噬血细胞性淋巴组织细胞增生症：一项药物警戒研究
J Clin Med. 2023 Mar 2;12(5):1985. doi: 10.3390/jcm12051985.
6
Systemic inflammatory syndromes as life-threatening side effects of immune checkpoint inhibitors: case report and systematic review of the literature.免疫检查点抑制剂的致命性系统性炎症综合征：病例报告和文献系统评价。
J Immunother Cancer. 2023 Mar;11(3). doi: 10.1136/jitc-2022-005841.